MAIA Biotechnology, Inc.
MAIA
$2.50
$0.1556.62%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 33.80% | -13.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.48% | 9.78% | |||
| Operating Income | -19.48% | -9.78% | |||
| Income Before Tax | -30.55% | 69.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -30.55% | 69.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.55% | 69.19% | |||
| EBIT | -19.48% | -9.78% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -24.54% | 71.37% | |||
| Normalized Basic EPS | -24.58% | 71.35% | |||
| EPS Diluted | -24.54% | 71.37% | |||
| Normalized Diluted EPS | -24.58% | 71.35% | |||
| Average Basic Shares Outstanding | 4.80% | 7.62% | |||
| Average Diluted Shares Outstanding | 4.80% | 7.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||